AR015966A1 - Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito - Google Patents
Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de pruritoInfo
- Publication number
- AR015966A1 AR015966A1 ARP980105131A ARP980105131A AR015966A1 AR 015966 A1 AR015966 A1 AR 015966A1 AR P980105131 A ARP980105131 A AR P980105131A AR P980105131 A ARP980105131 A AR P980105131A AR 015966 A1 AR015966 A1 AR 015966A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- pde4 inhibitor
- treatment
- prurite
- inhibitor compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6374697P | 1997-10-17 | 1997-10-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR015966A1 true AR015966A1 (es) | 2001-05-30 |
Family
ID=22051225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105131A AR015966A1 (es) | 1997-10-17 | 1998-10-15 | Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1030666A4 (xx) |
JP (1) | JP2001520196A (xx) |
KR (1) | KR20010031149A (xx) |
CN (1) | CN1306426A (xx) |
AR (1) | AR015966A1 (xx) |
AU (1) | AU740875B2 (xx) |
BR (1) | BR9814080A (xx) |
CA (1) | CA2306985A1 (xx) |
CO (1) | CO4810374A1 (xx) |
CZ (1) | CZ20001376A3 (xx) |
HU (1) | HUP0003792A3 (xx) |
IL (1) | IL135581A0 (xx) |
NO (1) | NO20001847D0 (xx) |
NZ (1) | NZ503551A (xx) |
PL (1) | PL341062A1 (xx) |
TR (1) | TR200001040T2 (xx) |
WO (1) | WO1999020280A1 (xx) |
ZA (1) | ZA989450B (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
CA2436535A1 (en) | 2001-01-31 | 2002-08-08 | Prizer Products Inc. | Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
EE200300362A (et) | 2001-01-31 | 2003-12-15 | Pfizer Products Inc. | PDE4 isosüümide inhibiitoritena kasutatavad tiasolüül-, oksasolüül-, pürrolüül- ja imidasolüülhappeamiidi derivaadid |
HUP0302891A2 (hu) | 2001-01-31 | 2003-12-29 | Pfizer Products Inc. | PDE4 izoenzimek inhibitoraiként alkalmazható éterszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
US20030175314A1 (en) * | 2001-11-19 | 2003-09-18 | Didriksen Erik Johannes | Pharmaceutical composition for dermal application |
EP1647274A4 (en) * | 2003-07-17 | 2008-12-10 | Ono Pharmaceutical Co | REMEDY AGAINST PRURIT COMPRISING A PIPERIDINE DERIVATIVE AS AN ACTIVE INGREDIENT |
JP2005187458A (ja) * | 2003-12-04 | 2005-07-14 | Santen Pharmaceut Co Ltd | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
WO2005053672A1 (ja) * | 2003-12-04 | 2005-06-16 | Santen Pharmaceutical Co., Ltd. | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
WO2005077950A2 (en) | 2004-02-14 | 2005-08-25 | Smithkline Beecham Corporation | Medicaments with hm74a receptor activity |
JP2008137892A (ja) * | 2005-03-04 | 2008-06-19 | Eisai Co Ltd | 止痒剤 |
BRPI0614270A2 (pt) | 2005-08-10 | 2011-03-22 | Smithkline Beecham Corp | derivados xantina como seletivos agonistas de ha74a |
TWI404709B (zh) * | 2006-02-21 | 2013-08-11 | Eisai R&D Man Co Ltd | 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives |
EP1992622B1 (en) * | 2006-02-21 | 2011-07-27 | Eisai R&D Management Co., Ltd. | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
EP2123641A4 (en) | 2007-02-16 | 2011-06-22 | Eisai R&D Man Co Ltd | CRYSTAL, AMORPHOUS FORM AND METHYL N-Ý3- (6,7-DIMETHOXY-2-METHYLAMINOQUINAZOLINE-4-YL) PHENYLENE TEREPHTALIC ACID SALT |
CN102336717B (zh) | 2007-08-17 | 2013-09-18 | 卫材R&D管理有限公司 | 喹唑啉衍生物 |
US8513269B2 (en) | 2007-08-17 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Preparation for external use |
US20140121240A1 (en) | 2011-06-28 | 2014-05-01 | Maruho Co., Ltd. | Novel pharmaceutical composition |
EA034139B1 (ru) | 2015-01-30 | 2020-01-09 | Шаньтонь Фарма Ко., Лтд. | Профилактика или лечение мочекислых или подагрических заболеваний |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0563168B1 (en) * | 1990-12-21 | 2000-07-05 | Beecham Group Plc | Xanthine derivatives |
ATE224386T1 (de) * | 1996-03-26 | 2002-10-15 | Altana Pharma Ag | Neue in 6-position substituierte phenanthridine |
ES2187775T3 (es) * | 1996-05-15 | 2003-06-16 | Altana Pharma Ag | Imidazopiridinas. |
DE69817548T2 (de) * | 1997-03-07 | 2004-06-17 | Altana Pharma Ag | Tetrazole derivate |
PL336464A1 (en) * | 1997-03-18 | 2000-06-19 | Basf Ag | Method of and compositions for modulating reactivity in respect to corticosteroids i |
WO1998055481A1 (en) * | 1997-06-03 | 1998-12-10 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
-
1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/es not_active Application Discontinuation
- 1998-10-16 PL PL98341062A patent/PL341062A1/xx unknown
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/ko not_active Application Discontinuation
- 1998-10-16 ZA ZA989450A patent/ZA989450B/xx unknown
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/hu unknown
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/xx unknown
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/cs unknown
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Application Discontinuation
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 CO CO98060225A patent/CO4810374A1/es unknown
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/pt not_active IP Right Cessation
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/ja not_active Withdrawn
- 1998-10-16 CN CN98810066A patent/CN1306426A/zh active Pending
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 IL IL13558198A patent/IL135581A0/xx unknown
-
2000
- 2000-04-10 NO NO20001847A patent/NO20001847D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL135581A0 (en) | 2001-05-20 |
ZA989450B (en) | 1999-04-19 |
AU740875B2 (en) | 2001-11-15 |
TR200001040T2 (tr) | 2001-01-22 |
CA2306985A1 (en) | 1999-04-29 |
KR20010031149A (ko) | 2001-04-16 |
AU1093899A (en) | 1999-05-10 |
WO1999020280A1 (en) | 1999-04-29 |
CZ20001376A3 (cs) | 2002-06-12 |
NZ503551A (en) | 2002-05-31 |
CN1306426A (zh) | 2001-08-01 |
HUP0003792A3 (en) | 2001-12-28 |
EP1030666A4 (en) | 2002-10-16 |
BR9814080A (pt) | 2000-09-26 |
HUP0003792A2 (hu) | 2001-10-28 |
CO4810374A1 (es) | 1999-06-30 |
NO20001847L (no) | 2000-04-10 |
NO20001847D0 (no) | 2000-04-10 |
EP1030666A1 (en) | 2000-08-30 |
PL341062A1 (en) | 2001-03-26 |
JP2001520196A (ja) | 2001-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR015966A1 (es) | Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito | |
BR0108584A (pt) | Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva | |
BR0111034A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids | |
ES2063073T3 (es) | Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios. | |
ES2149264T3 (es) | Agente terapeutico para el tratamiento de melanomas. | |
CL2009001279A1 (es) | Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03). | |
AR012671A1 (es) | Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos | |
BR0111196A (pt) | Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus | |
BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
YU49315B (sh) | Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje | |
ES2144119T3 (es) | Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada. | |
BRPI0308663B8 (pt) | uso de inibidores de il-18 para o tratamento e/ou prevenção de doenças vasculares periféricas | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
DE69906963D1 (de) | Efavirenz enthaltende gepresste tablettenformulierug | |
HUP9802971A1 (hu) | Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére | |
BR0213293A (pt) | Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia | |
CO5570661A2 (es) | Combinaciones que comprenden inhibidores de cox-2 y aspirina | |
BR0206549A (pt) | Uso de flumazenil na produção de uma droga para o tratamento de dependência de álcool | |
AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
BR0012169A (pt) | Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia | |
BR0206819A (pt) | Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca | |
BR0209155A (pt) | Tablete farmacêutico tendo um teor de api elevado | |
MXPA03010672A (es) | Composicion para el tratamiento regenerativo de enfermedades del cartilago. | |
EE200100188A (et) | Optiliselt aktiivne püridüül-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |